Rare diseases
Investigational molecules
Locations
Back to Italy987 clinical trials in Candiolo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
ItalyStudy of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies
ItalyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
ItalyStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
ItalyLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
ItalyStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
ItalyStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
ItalyStudy of luxdegalutamide and abiraterone combination in adult men with metastatic hormone-sensitive prostate cancer
ItalyStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
ItalyStudy comparing valemetostat tosylate plus pembrolizumab versus pembrolizumab alone in patients with advanced non-small cell lung cancer with high PD-L1 expression
ItalyStudy of baxdrostat compared to placebo to treat adults with primary aldosteronism
ItalyStudy of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on blood cancers including innovative treatments for myelodysplastic syndromes, follicular lymphoma, and chronic myelomonocytic leukemia. Studies evaluate novel drug combinations and maintenance therapies to improve patient outcomes.
Trials investigate targeted therapies and immunotherapy approaches for better disease management.
Comprehensive research on lung cancer, breast cancer, and colorectal cancer. Studies explore combination therapies involving immunotherapy, targeted agents, and conventional treatments to enhance treatment efficacy.
Focus on personalized medicine approaches and biomarker-driven treatment selection.
Dedicated research into sarcomas, head and neck cancers, and other rare malignancies. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Emphasis on developing effective treatments for cancers with limited therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
